Skip to content

Effects of Smartphone Heart Failure APPs and Remote Cardiac Rehabilitation on Prognosis and Exercise Capacity in Acute Coronary Syndrome Patients (SHARE-CR study)

Effects of Smartphone Heart Failure APPs and Remote Cardiac Rehabilitation Using Mobile Health on Prognosis and Exercise Capacity in Acute Coronary Syndrome Patients (SHARE-CR study)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1040240079
Enrollment
84
Registered
2024-08-29
Start date
2024-08-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome Acute coronary syndrome

Interventions

In the intervention group, a Fitbit will be linked to the Heart Signs app for heart failure management and remote exercise guidance based on heart rate and exercise intensity during exercise. The cont
Self care, Remote rehabilitation, Personal health record, Application, Smartphone, Smart watch

Sponsors

Fujimoto Naoki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients are 18 years of age or older 2) Patients with early revascularization for ACS who are scheduled for discharge home 3) Patients with NYHA class I-III HF symptoms and HF Stage B or C 4) Patients with a smartphone that can be connected to the Internet environment and on which the application can be installed. 5) Patients who agree to participate in research

Exclusion criteria

Exclusion criteria: 1) Patients who do not have access to an Internet environment or do not have a smartphone capable of installing applications 2) Patients who are unable to use a smartphone due to cognitive or physical decline or disability 3) Patients who cannot install the application or agree to the terms of service 4) Patients who had a stroke, transient ischemic attack, or surgery on the cardiovascular, carotid, or other major cardiac vessels within 3 months 5) Patients who are unable to walk or do other physical activities 6) Patients with residual unstable angina pectoris 7) Patients with scheduled cardiac bypass surgery 8) Patients who are expected to be hospitalized for longer than 28 days for ACS 9) Patients who are pregnant, possibly pregnant, or lactating patients 10) Patients whose heart failure symptoms are NYHA IV and require continuous inpatient care 11) Patients with persistent atrial fibrillation 12) Patients who will participate in outpatient cardiac rehabilitation 13) Patients who are deemed inappropriate for inclusion in the study by the principal investigator or co-investigator 14) Patients with heart failure who have already participated in the Heart Signs Study 15) Patients who wish to continue using the conventional paper-based heart failure handbook

Design outcomes

Primary

MeasureTime frame
Change in peak VO2

Secondary

MeasureTime frame
Percent change in peak VO2, anaerobic threshold (AT), 24-hour blood pressure by 24-hour blood pressure monitor (ABPM), daytime blood pressure, nighttime blood pressure, evaluation of blood pressure variability, left ventricular systolic and diastolic function, left ventricular volume, left ventricular ejection fraction, left and right ventricular yesterday by echocardiography, Kansas City as quality of life index Cardiomyopathy Questionnaire (KCCQ)-CSS, KCCQ-TSS, KCCQ-OSS change from baseline, Fitbit information: amount of exercise (steps, exercise duration, distance traveled, METs), heart rate during exercise, heart failure hospitalizations and cardiovascular adverse events during the 6- and 12-month observation periods

Contacts

Public ContactKenta Uno

Mie University Graduate School of Medicine

heartsign@med.mie-u.ac.jp+81-59-231-5015

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026